{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T20:47:54Z","timestamp":1789678074421,"version":"4.0.1"},"reference-count":71,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","seminarsinnephrology.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Nephrology"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/j.semnephrol.2017.05.004","type":"journal-article","created":{"date-parts":[[2017,7,13]],"date-time":"2017-07-13T08:05:25Z","timestamp":1499933125000},"page":"327-336","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Fertility, Contraception, and Novel Reproductive Technologies in Chronic Kidney Disease"],"prefix":"10.1016","volume":"37","author":[{"given":"Sofia B.","family":"Ahmed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy S.","family":"Vitek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean L.","family":"Holley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semnephrol.2017.05.004_bib1","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1053\/j.ackd.2013.01.003","article-title":"Changes in fertility and hormone replacement therapy in kidney disease","volume":"20","author":"Holley","year":"2013","journal-title":"Adv Chronic Kidney Dis"},{"key":"10.1016\/j.semnephrol.2017.05.004_bib2","doi-asserted-by":"crossref","first-page":"881","DOI":"10.2215\/CJN.03870412","article-title":"Female sexual dysfunction in ESRD: an underappreciated epidemic?","volume":"7","author":"Weisbord","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2017.05.004_bib3","doi-asserted-by":"crossref","first-page":"974","DOI":"10.2215\/CJN.12601211","article-title":"Sexual dysfunction in women with ESRD requiring hemodialysis","volume":"7","author":"Strippoli","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2017.05.004_bib4","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1053\/j.ajkd.2010.06.016","article-title":"Prevalence and correlates of self-reported sexual dysfunction in CKD: a meta-analysis of observational studies","volume":"56","author":"Navaneethan","year":"2010","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2017.05.004_bib5","doi-asserted-by":"crossref","first-page":"128","DOI":"10.2215\/CJN.05470513","article-title":"Sexual function, activity, and satisfaction among women receiving maintenance hemodialysis","volume":"9","author":"Mor","year":"2014","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2017.05.004_bib6","doi-asserted-by":"crossref","first-page":"6","DOI":"10.2215\/CJN.11831113","article-title":"Sexual Inactivity among hemodialysis patients: the patients\u05f3 perspective","volume":"9","author":"Finkelstein","year":"2014","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2017.05.004_bib7","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1093\/humrep\/12.4.667","article-title":"Undetected gynaecological disorders in women with renal disease","volume":"12","author":"Cochrane","year":"1997","journal-title":"Human Reprod"},{"key":"10.1016\/j.semnephrol.2017.05.004_bib8","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0272-6386(97)90120-7","article-title":"Gynecologic and reproductive issues in women on dialysis","volume":"29","author":"Holley","year":"1997","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2017.05.004_bib9","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1093\/ndt\/gfh279","article-title":"Endometrial morphology and pituitary-gonadal axis dysfunction in women of reproductive age undergoing chronic haemodialysis--a multicentre study","volume":"19","author":"Matuszkiewicz-Rowinska","year":"2004","journal-title":"Nephrol Dial Transplant"},{"issue":"Suppl 2","key":"10.1016\/j.semnephrol.2017.05.004_bib10","doi-asserted-by":"crossref","first-page":"S192","DOI":"10.1177\/089686080302302s40","article-title":"Health issues in dialysis-dependent female patients","volume":"23","author":"Shanmugavadivoo","year":"2003","journal-title":"Perit Dial Int"},{"key":"10.1016\/j.semnephrol.2017.05.004_bib11","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1525-139X.1993.tb00273.x","article-title":"Reproductive endocrinology and pregnancy in women on hemodialysis","volume":"6","author":"Ginsburg","year":"1993","journal-title":"Semin Dial"},{"key":"10.1016\/j.semnephrol.2017.05.004_bib12","doi-asserted-by":"crossref","first-page":"21","DOI":"10.7326\/0003-4819-93-1-21","article-title":"Ovarian function in chronic renal failure: evidence suggesting hypothalamic anovulation","volume":"93","author":"Lim","year":"1980","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.semnephrol.2017.05.004_bib13","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1053\/j.ackd.2004.07.004","article-title":"The hypothalamic-pituitary axis in men and women with chronic kidney disease","volume":"11","author":"Holley","year":"2004","journal-title":"Adv Chronic Kidney Dis"},{"key":"10.1016\/j.semnephrol.2017.05.004_bib14","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1440-1797.2011.01520.x","article-title":"Changes in serum prolactin, sex hormones and thyroid function with alternate nightly nocturnal home haemodialysis","volume":"17","author":"van Eps","year":"2012","journal-title":"Nephrology (Carlton)"},{"key":"10.1016\/j.semnephrol.2017.05.004_bib15","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1053\/j.ackd.2013.01.010","article-title":"End-stage renal disease and pregnancy","volume":"20","author":"Nadeau-Fredette","year":"2013","journal-title":"Adv Chronic Kidney Dis"},{"key":"10.1016\/j.semnephrol.2017.05.004_bib16","doi-asserted-by":"crossref","first-page":"392","DOI":"10.2215\/CJN.04110907","article-title":"Successful pregnancies on nocturnal home hemodialysis","volume":"3","author":"Barua","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2017.05.004_bib17","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1053\/j.ackd.2013.06.005","article-title":"Women and transplantation: fertility, sexuality, pregnancy, contraception","volume":"20","author":"Josephson","year":"2013","journal-title":"Adv Chronic Kidney Dis"},{"key":"10.1016\/j.semnephrol.2017.05.004_bib18","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1111\/petr.12554","article-title":"Sexually transmitted infections in pediatric renal transplant recipients: time to take notice!","volume":"19","author":"Ashoor","year":"2015","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.semnephrol.2017.05.004_bib19","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1681\/ASN.2014050459","article-title":"Risk of adverse pregnancy outcomes in women with CKD","volume":"26","author":"Piccoli","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2017.05.004_bib20","unstructured":"2015 Quick reference chart for the WHO medical eligibility criteria for contraceptive use. 2015. [2016 September 7]. Available from: www.fhi360.org\/sites\/default\/files\/media\/documents\/chart-medical-eligibility-contraceptives-english.pdf."},{"key":"10.1016\/j.semnephrol.2017.05.004_bib21","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1093\/rheumatology\/32.3.227","article-title":"Contraceptive practice in women with systemic lupus erythematosus","volume":"32","author":"Julkunen","year":"1993","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.semnephrol.2017.05.004_bib22","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1056\/NEJMoa050817","article-title":"A trial of contraceptive methods in women with systemic lupus erythematosus","volume":"353","author":"Sanchez-Guerrero","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semnephrol.2017.05.004_bib23","first-page":"99","article-title":"Intrauterine contraceptive device failures in renal transplant patients","volume":"26","author":"Zerner","year":"1981","journal-title":"J Reprod Med"},{"key":"10.1016\/j.semnephrol.2017.05.004_bib24","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.contraception.2011.12.008","article-title":"Use of the levonorgestrel-releasing intrauterine system in renal transplant recipients: a retrospective case review","volume":"86","author":"Ramhendar","year":"2012","journal-title":"Contraception"},{"key":"10.1016\/j.semnephrol.2017.05.004_bib25","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0010-7824(99)00061-X","article-title":"Effect of the levonorgestrel-releasing intrauterine system on uterine myomas in a renal transplant patient","volume":"60","author":"Fong","year":"1999","journal-title":"Contraception"},{"key":"10.1016\/j.semnephrol.2017.05.004_bib26","doi-asserted-by":"crossref","first-page":"146","DOI":"10.5414\/CN107391","article-title":"Migration of an intrauterine device and peritonitis in a peritoneal dialysis patient","volume":"80","author":"Bieber","year":"2013","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.semnephrol.2017.05.004_bib27","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1177\/089686080202200420","article-title":"Intrauterine device-related peritonitis in a patient on CAPD","volume":"22","author":"Plaza","year":"2002","journal-title":"Perit Dial Int"},{"key":"10.1016\/j.semnephrol.2017.05.004_bib28","first-page":"24","article-title":"Pneumococcal peritonitis complicating CAPD--was the indwelling intrauterine device to blame?","volume":"35","author":"Korzets","year":"1991","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.semnephrol.2017.05.004_bib29","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1177\/089686088600600313","article-title":"Peritonitis due to an intrauterine contraceptive device in a patient on CAPD","volume":"6","author":"Stuck","year":"1986","journal-title":"Perit Dial Bull"},{"key":"10.1016\/j.semnephrol.2017.05.004_bib30","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1161\/01.CIR.94.3.483","article-title":"Prospective study of oral contraceptives and hypertension among women in the United States","volume":"94","author":"Chasan-Taber","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.semnephrol.2017.05.004_bib31","doi-asserted-by":"crossref","first-page":"d6423","DOI":"10.1136\/bmj.d6423","article-title":"Risk of venous thromboembolism from use of oral contraceptives containing different progestogens and oestrogen doses: Danish cohort study, 2001-9","volume":"343","author":"Lidegaard","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.semnephrol.2017.05.004_bib32","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1097\/01.ASN.0000114555.16297.5A","article-title":"Effects of oral contraceptive use on the renal and systemic vascular response to angiotensin II infusion","volume":"15","author":"Ahmed","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2017.05.004_bib33","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.2337\/diacare.28.8.1988","article-title":"Oral contraceptives, angiotensin-dependent renal vasoconstriction, and risk of diabetic nephropathy","volume":"28","author":"Ahmed","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1016\/j.semnephrol.2017.05.004_bib34","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1161\/01.HYP.33.1.90","article-title":"Renal characteristics and effect of angiotensin suppression in oral contraceptive users","volume":"33","author":"Ribstein","year":"1999","journal-title":"Hypertension"},{"key":"10.1016\/j.semnephrol.2017.05.004_bib35","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1001\/archinte.161.16.2000","article-title":"Oral contraceptive use and hormone replacement therapy are associated with microalbuminuria","volume":"161","author":"Monster","year":"2001","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.semnephrol.2017.05.004_bib36","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1001\/jama.285.18.2347","article-title":"Evaluation of contraceptive efficacy and cycle control of a transdermal contraceptive patch vs an oral contraceptive: a randomized controlled trial","volume":"285","author":"Audet","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.semnephrol.2017.05.004_bib37","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1016\/S0015-0282(01)03275-7","article-title":"Contraceptive efficacy and cycle control with the Ortho Evra\/Evra transdermal system: the analysis of pooled data","volume":"77","author":"Zieman","year":"2002","journal-title":"Fertil Steril"},{"key":"10.1016\/j.semnephrol.2017.05.004_bib38","doi-asserted-by":"crossref","first-page":"F535","DOI":"10.1152\/ajprenal.00602.2014","article-title":"Transdermal contraception and the renin-angiotensin-aldosterone system in premenopausal women","volume":"308","author":"Odutayo","year":"2015","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.semnephrol.2017.05.004_bib39","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.contraception.2008.07.004","article-title":"Effects of switching from oral to transdermal or transvaginal contraception on markers of thrombosis","volume":"78","author":"Jensen","year":"2008","journal-title":"Contraception"},{"key":"10.1016\/j.semnephrol.2017.05.004_bib40","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1016\/j.transproceed.2010.03.132","article-title":"The contraceptive vaginal ring in women with renal and liver transplantation: analysis of preliminary results","volume":"42","author":"Paternoster","year":"2010","journal-title":"Transplant Proc"},{"key":"10.1016\/j.semnephrol.2017.05.004_bib41","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.contraception.2011.01.021","article-title":"Contraceptive failure in the United States","volume":"83","author":"Trussell","year":"2011","journal-title":"Contraception"},{"key":"10.1016\/j.semnephrol.2017.05.004_bib42","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ajog.2004.07.041","article-title":"Double-blinded randomized controlled trial of estrogen supplementation in adolescent girls who receive depot medroxyprogesterone acetate for contraception","volume":"192","author":"Cromer","year":"2005","journal-title":"Am J Obstetr Gynecol"},{"key":"10.1016\/j.semnephrol.2017.05.004_bib43","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s00198-016-3714-4","article-title":"The impact of depot medroxygesteribe acetate on fracture risk: a case-control study from the UK","volume":"28","author":"Kywernitakis","year":"2017","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.semnephrol.2017.05.004_bib44","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.contraception.2007.10.005","article-title":"Bone density recovery after depot medroxyprogesterone acetate injectable contraception use","volume":"77","author":"Kaunitz","year":"2008","journal-title":"Contraception"},{"key":"10.1016\/j.semnephrol.2017.05.004_bib45","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1053\/j.ackd.2007.01.003","article-title":"Pregnancy and contraceptive counseling of women with chronic kidney disease and kidney transplants","volume":"14","author":"Watnick","year":"2007","journal-title":"Adv Chronic Kidney Dis"},{"key":"10.1016\/j.semnephrol.2017.05.004_bib46","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.ijgo.2011.01.016","article-title":"Medical abortion in women with impaired renal function","volume":"114","author":"Mittal","year":"2011","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.semnephrol.2017.05.004_bib47","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.contraception.2014.04.014","article-title":"Contraceptive awareness and birth control selection in female kidney and liver transplant recipients","volume":"90","author":"Szpotanska-Sikorska","year":"2014","journal-title":"Contraception"},{"key":"10.1016\/j.semnephrol.2017.05.004_bib48","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1097\/AOG.0b013e3182a5eda9","article-title":"Contraception and fertility awareness among women with solid organ transplants","volume":"122","author":"French","year":"2013","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.semnephrol.2017.05.004_bib49","first-page":"1","article-title":"U.S. medical eligibility criteria for contraceptive use, 2016","volume":"65","author":"Curtis","year":"2016","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.semnephrol.2017.05.004_bib50","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.contraception.2010.02.007","article-title":"Contraceptive use among solid organ transplant patients: a systematic review","volume":"82","author":"Paulen","year":"2010","journal-title":"Contraception"},{"key":"10.1016\/j.semnephrol.2017.05.004_bib51","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1097\/TP.0b013e31827c64de","article-title":"Contraceptive options for women with a history of solid-organ transplantation","volume":"95","author":"Krajewski","year":"2013","journal-title":"Transplantation"},{"key":"10.1016\/j.semnephrol.2017.05.004_bib52","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002922.pub2","article-title":"Treatment for lupus nephritis","volume":"1","author":"Flanc","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.semnephrol.2017.05.004_bib53","doi-asserted-by":"crossref","first-page":"366","DOI":"10.7326\/0003-4819-119-5-199309010-00003","article-title":"Risk for sustained amenorrhea in patients with systemic lupus erythematosus receiving intermittent pulse cyclophosphamide therapy","volume":"119","author":"Boumpas","year":"1993","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.semnephrol.2017.05.004_bib54","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1093\/humupd\/dms022","article-title":"How do chemotherapeutic agents damage the ovary?","volume":"18","author":"Morgan","year":"2012","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.semnephrol.2017.05.004_bib55","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0015-0282(16)49537-3","article-title":"Gonadal function in women treated with cyclophosphamide for childhood nephrotic syndrome: a long-term follow-up study","volume":"46","author":"Watson","year":"1986","journal-title":"Fertil Steril"},{"key":"10.1016\/j.semnephrol.2017.05.004_bib56","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1177\/096120339500400103","article-title":"Ovarian failure in oral cyclophosphamide treatment for systemic lupus erythematosus","volume":"4","author":"Wang","year":"1995","journal-title":"Lupus"},{"key":"10.1016\/j.semnephrol.2017.05.004_bib57","first-page":"2129","article-title":"Predictors of sustained amenorrhea from pulsed intravenous cyclophosphamide in premenopausal women with systemic lupus erythematosus","volume":"29","author":"Ioannidis","year":"2002","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semnephrol.2017.05.004_bib58","doi-asserted-by":"crossref","first-page":"3785","DOI":"10.1210\/jc.2013-1235","article-title":"Study of anti-Mullerian hormone and its relation to the subsequent probability of pregnancy in 112 patients with systemic lupus erythematosus, exposed or not to cyclophosphamide","volume":"98","author":"Morel","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.semnephrol.2017.05.004_bib59","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1002\/art.10461","article-title":"Immunosuppressive therapy in lupus nephritis: the Euro-Lupus Nephritis Trial, a randomized trial of low-dose versus high-dose intravenous cyclophosphamide","volume":"46","author":"Houssiau","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semnephrol.2017.05.004_bib60","doi-asserted-by":"crossref","first-page":"3096","DOI":"10.1002\/art.38790","article-title":"Treatment of lupus nephritis with abatacept: the Abatacept and Cyclophosphamide Combination Efficacy and Safety Study","volume":"66","author":"Group","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.semnephrol.2017.05.004_bib61","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1056\/NEJMoa031855","article-title":"Sequential therapies for proliferative lupus nephritis","volume":"350","author":"Contreras","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semnephrol.2017.05.004_bib62","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1136\/ard.2002.003574","article-title":"EULAR randomised controlled trial of pulse cyclophosphamide and methylprednisolone versus continuous cyclophosphamide and prednisolone followed by azathioprine and prednisolone in lupus nephritis","volume":"63","author":"Yee","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semnephrol.2017.05.004_bib63","doi-asserted-by":"crossref","first-page":"114","DOI":"10.7326\/0003-4819-116-2-114","article-title":"Progression and remission of renal disease in the Lupus Nephritis Collaborative Study. Results of treatment with prednisone and short-term oral cyclophosphamide","volume":"116","author":"Levey","year":"1992","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.semnephrol.2017.05.004_bib64","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1007\/s10067-014-2590-6","article-title":"Short-interval lower-dose intravenous cyclophosphamide as induction and maintenance therapy for lupus nephritis: a prospective observational study","volume":"33","author":"Zhang","year":"2014","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.semnephrol.2017.05.004_bib65","doi-asserted-by":"crossref","first-page":"624","DOI":"10.3109\/09513590.2011.650752","article-title":"Adjunctive GnRH-a treatment attenuates depletion of ovarian reserve associated with cyclophosphamide therapy in premenopausal SLE patients","volume":"28","author":"Marder","year":"2012","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.semnephrol.2017.05.004_bib66","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1002\/art.21263","article-title":"Use of a gonadotropin-releasing hormone analog for protection against premature ovarian failure during cyclophosphamide therapy in women with severe lupus","volume":"52","author":"Somers","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semnephrol.2017.05.004_bib67","unstructured":"Lupron Depot\u00ae -3 month 11.25 mg (leuprolide acetate for depot suspension) 3-month formulation 2012. [cited 2016 September 7]. Available from: http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2012\/019943s031,020011s038,020708s031lbl.pdf."},{"key":"10.1016\/j.semnephrol.2017.05.004_bib68","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1002\/1529-0131(200003)43:3<550::AID-ANR10>3.0.CO;2-Y","article-title":"Ovulation induction and in vitro fertilization in systemic lupus erythematosus and antiphospholipid syndrome","volume":"43","author":"Guballa","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semnephrol.2017.05.004_bib69","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.fertnstert.2012.09.028","article-title":"Mature oocyte cryopreservation: a guideline","volume":"99","year":"2013","journal-title":"Fertil Steril"},{"key":"10.1016\/j.semnephrol.2017.05.004_bib70","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1093\/humrep\/dev128","article-title":"Live birth after autograft of ovarian tissue cryopreserved during childhood","volume":"30","author":"Demeestere","year":"2015","journal-title":"Human Reprod"},{"key":"10.1016\/j.semnephrol.2017.05.004_bib71","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/j.fertnstert.2013.03.030","article-title":"Restoration of ovarian activity and pregnancy after transplantation of cryopreserved ovarian tissue: a review of 60 cases of reimplantation","volume":"99","author":"Donnez","year":"2013","journal-title":"Fertil Steril"}],"container-title":["Seminars in Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0270929517300335?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0270929517300335?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,12]],"date-time":"2020-10-12T05:26:48Z","timestamp":1602480408000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0270929517300335"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":71,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["S0270929517300335"],"URL":"https:\/\/doi.org\/10.1016\/j.semnephrol.2017.05.004","relation":{},"ISSN":["0270-9295"],"issn-type":[{"value":"0270-9295","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fertility, Contraception, and Novel Reproductive Technologies in Chronic Kidney Disease","name":"articletitle","label":"Article Title"},{"value":"Seminars in Nephrology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semnephrol.2017.05.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}